Literature DB >> 15670905

Exploring human adenosine A3 receptor complementarity and activity for adenosine analogues modified in the ribose and purine moiety.

Philippe Van Rompaey1, Kenneth A Jacobson, Ariel S Gross, Zhan-Guo Gao, Serge Van Calenbergh.   

Abstract

In this paper we investigated the influence on affinity, selectivity and intrinsic activity upon modification of the adenosine agonist scaffold at the 3'- and 5'-positions of the ribofuranosyl moiety and the 2- and N6-positions of the purine base. This resulted in the synthesis of various analogues, that is, 3-12 and 24-33, with good hA3AR selectivity and moderate-to-high affinities (as in 32, Ki=27 nM). Interesting was the ability to tune the intrinsic activity depending on the substituent introduced at the 3'-position.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15670905      PMCID: PMC3460517          DOI: 10.1016/j.bmc.2004.11.044

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  43 in total

1.  The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells.

Authors:  V Ramkumar; G L Stiles; M A Beaven; H Ali
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

2.  Adenosine A3 receptors in mast cells.

Authors:  M A Beaven; V Ramkumar; H Ali
Journal:  Trends Pharmacol Sci       Date:  1994-01       Impact factor: 14.819

3.  G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain.

Authors:  M P Abbracchio; R Brambilla; S Ceruti; H O Kim; D K von Lubitz; K A Jacobson; F Cattabeni
Journal:  Mol Pharmacol       Date:  1995-12       Impact factor: 4.436

4.  Molecular cloning and characterization of the human A3 adenosine receptor.

Authors:  C A Salvatore; M A Jacobson; H E Taylor; J Linden; R G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

5.  Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.

Authors:  J Linden; H E Taylor; A S Robeva; A L Tucker; J H Stehle; S A Rivkees; J S Fink; S M Reppert
Journal:  Mol Pharmacol       Date:  1993-09       Impact factor: 4.436

6.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

7.  The effects of adenosine A3 receptor stimulation on seizures in mice.

Authors:  D K Von Lubitz; M F Carter; S I Deutsch; R C Lin; J Mastropaolo; Y Meshulam; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1995-02-24       Impact factor: 4.432

8.  2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.

Authors:  H O Kim; X D Ji; S M Siddiqi; M E Olah; G L Stiles; K A Jacobson
Journal:  J Med Chem       Date:  1994-10-14       Impact factor: 7.446

9.  Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.

Authors:  K A Jacobson; S M Siddiqi; M E Olah; X D Ji; N Melman; K Bellamkonda; Y Meshulam; G L Stiles; H O Kim
Journal:  J Med Chem       Date:  1995-05-12       Impact factor: 7.446

10.  Adenosine A3 receptor stimulation and cerebral ischemia.

Authors:  D K Von Lubitz; R C Lin; P Popik; M F Carter; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1994-09-22       Impact factor: 4.432

View more
  6 in total

Review 1.  Neoceptors: reengineering GPCRs to recognize tailored ligands.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Bruce T Liang
Journal:  Trends Pharmacol Sci       Date:  2007-02-05       Impact factor: 14.819

Review 2.  Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.

Authors:  Kenneth A Jacobson; Athena M Klutz; Dilip K Tosh; Andrei A Ivanov; Delia Preti; Pier Giovanni Baraldi
Journal:  Handb Exp Pharmacol       Date:  2009

3.  Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists.

Authors:  Zhan-Guo Gao; Heng T Duong; Tatiana Sonina; Soo-Kyung Kim; Philippe Van Rompaey; Serge Van Calenbergh; Liaman Mamedova; Hea Ok Kim; Myong Jung Kim; Ae Yil Kim; Bruce T Liang; Lak Shin Jeong; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2006-05-04       Impact factor: 7.446

4.  Translocation of arrestin induced by human A(3) adenosine receptor ligands in an engineered cell line: comparison with G protein-dependent pathways.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Pharmacol Res       Date:  2008-03-08       Impact factor: 7.658

Review 5.  Selected β2-, β3- and β2,3-Amino Acid Heterocyclic Derivatives and Their Biological Perspective.

Authors:  Urszula Bąchor; Marcin Mączyński
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

6.  Synthesis of N-methyl-d-ribopyranuronamide nucleosides.

Authors:  Shiqiong Yang; Roger Busson; Piet Herdewijn
Journal:  Tetrahedron       Date:  2008-08-13       Impact factor: 2.457

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.